Premium
Annovis Bio Inc (ANVS)
NYSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company’s lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer’s disease, as well as in open-label phase 3 to treat parkinson’s disease. It also deve... Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company’s lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer’s disease, as well as in open-label phase 3 to treat parkinson’s disease. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer’s disease and dementia. Annovis Bio, Inc. was incorporated in 2008 and is headquartered in Malvern, Pennsylvania. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.19 | 11.0465116279 | 1.72 | 2.02 | 1.71 | 808790 | 1.89402194 | CS |
| 4 | -0.01 | -0.520833333333 | 1.92 | 2.02 | 1.645 | 914185 | 1.77737798 | CS |
| 12 | 0.33 | 20.8860759494 | 1.58 | 2.4705 | 1.55 | 1134204 | 1.93598844 | CS |
| 26 | -1.94 | -50.3896103896 | 3.85 | 4.14 | 1.5407 | 842812 | 2.12733272 | CS |
| 52 | -0.43 | -18.3760683761 | 2.34 | 5.5 | 1.5407 | 962054 | 2.64332093 | CS |
| 156 | -11.89 | -86.1594202899 | 13.8 | 22.49 | 1.11 | 658031 | 5.58529175 | CS |
| 260 | -93.97 | -98.0079265749 | 95.88 | 132 | 1.11 | 454852 | 10.20383786 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
